UI Health Care is leading a clinical trial that is demonstrating a completely new way of harnessing the immune system to fight cancer.

Second NET SPORE grant at Iowa focused on translating research into improved treatments for patients

Michael J. Welsh, MD honored with prestigious Lasker Award for fundamental cystic fibrosis discoveries that helped create life-saving therapies.

The Icahn School of Medicine at Mount Sinai has awarded its prestigious 2025 Yergin-New International Prize for Biomedical Research to Michael J. Welsh, MD, professor in Pulmonary, Critical Care, & Occupational Medicine, recognizing his groundbreaking contributions to cystic fibrosis (CF) research.

The World Gastroenterology Organisation (WGO) recently recognized Dr. Douglas LaBrecque’s legacy by selecting him for the Master of the WGO Award—the highest honor bestowed by the organization.

Researchers uncovered a surprising player in the repair process: a protein called junctophilin-2 (Jph2).

A new study, led by Eric Taylor, PhD and Rebecca Dodd, PhD, delving into the genetic drivers of a rare and aggressive childhood cancer called Malignant Peripheral Nerve Sheath Tumor (MPNST) has revealed metabolic frailties in the cancer cells that might be exploited to improved treatments for patients.

In a retrospective study featured in JACC: Advances, researchers identified an alarming national trend: providers infrequently test younger patients with CHB for cardiac sarcoidosis, despite American Heart Association guidelines recommending CS screening in such cases.

Adeyinka Taiwo, MBBS, MSc, FRCP, clinical assistant professor in Endocrinology and Metabolism, has published novel research laying the foundation for continued study of T1D comorbidity with the nation’s most common chronic liver disease.

Cancer care at UI Health Care is ranked ranked among the nation’s top 50, and Gastroenterology and Pulmonology are among the top 10%, according to the 2025-2026 rankings published by U.S. News & World Report.